Target validation of acid-sensing ion channel inhibitors to stop disease progression and manage pain in MS (2023–2026)
- Grant type:
- National Multiple Sclerosis Society-US
- Researchers:
-
-
- Funded by:
- National Multiple Sclerosis Society-US
